Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4025.50 | 1445 / 1445 | 100% | 65.80 | 183 / 183 |
intestine | 100% | 4208.60 | 966 / 966 | 100% | 61.22 | 527 / 527 |
ovary | 100% | 6278.36 | 180 / 180 | 100% | 42.48 | 430 / 430 |
stomach | 100% | 2950.35 | 359 / 359 | 100% | 57.55 | 286 / 286 |
breast | 100% | 4661.77 | 459 / 459 | 100% | 66.60 | 1117 / 1118 |
lung | 100% | 3600.89 | 577 / 578 | 100% | 56.89 | 1155 / 1155 |
brain | 100% | 5139.18 | 2640 / 2642 | 100% | 76.14 | 704 / 705 |
prostate | 100% | 3705.63 | 245 / 245 | 100% | 44.37 | 500 / 502 |
uterus | 100% | 5101.52 | 170 / 170 | 100% | 66.08 | 457 / 459 |
bladder | 100% | 4424.38 | 21 / 21 | 99% | 58.29 | 501 / 504 |
thymus | 100% | 4226.64 | 653 / 653 | 99% | 55.30 | 599 / 605 |
pancreas | 99% | 2198.73 | 326 / 328 | 99% | 45.68 | 177 / 178 |
skin | 100% | 4869.80 | 1808 / 1809 | 97% | 53.48 | 460 / 472 |
adrenal gland | 100% | 4263.93 | 258 / 258 | 97% | 46.99 | 224 / 230 |
kidney | 100% | 3803.65 | 89 / 89 | 97% | 43.87 | 876 / 901 |
liver | 99% | 1616.91 | 223 / 226 | 86% | 19.38 | 349 / 406 |
blood vessel | 100% | 4163.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 69.40 | 29 / 29 |
spleen | 100% | 3577.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.62 | 1 / 1 |
adipose | 100% | 4439.73 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2609.10 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2457.96 | 832 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 28.93 | 74 / 80 |
peripheral blood | 63% | 3057.31 | 584 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006397 | Biological process | mRNA processing |
GO_0180010 | Biological process | co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway |
GO_0031124 | Biological process | mRNA 3'-end processing |
GO_0010608 | Biological process | post-transcriptional regulation of gene expression |
GO_0051262 | Biological process | protein tetramerization |
GO_0110104 | Biological process | mRNA alternative polyadenylation |
GO_0030154 | Biological process | cell differentiation |
GO_0051290 | Biological process | protein heterotetramerization |
GO_2000975 | Biological process | positive regulation of pro-B cell differentiation |
GO_2000738 | Biological process | positive regulation of stem cell differentiation |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005813 | Cellular component | centrosome |
GO_0005847 | Cellular component | mRNA cleavage and polyadenylation specificity factor complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005849 | Cellular component | mRNA cleavage factor complex |
GO_0042382 | Cellular component | paraspeckles |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | NUDT21 |
Protein name | Nudix hydrolase 21 Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) Cleavage and polyadenylation specificity factor subunit 5 (Cleavage and polyadenylation specificity factor 25 kDa subunit) (CPSF 25 kDa subunit) (Cleavage factor Im complex 25 kDa subunit) (CFIm25) (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21) (Nudix hydrolase 21) (Pre-mRNA cleavage factor Im 68 kDa subunit) |
Synonyms | CPSF5 CPSF25 CFIM25 |
Description | FUNCTION: Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs . CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals) . Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation . The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs . NUDT21/CPSF5 activates indirectly the mRNA 3'-processing machinery by recruiting CPSF6 and/or CPSF7 . Binds to 5'-UGUA-3' elements localized upstream of pA signals that act as enhancers of pre-mRNA 3'-end processing . The homodimer mediates simultaneous sequence-specific recognition of two 5'-UGUA-3' elements within the pre-mRNA . Plays a role in somatic cell fate transitions and pluripotency by regulating widespread changes in gene expression through an APA-dependent function (By similarity). Binds to chromatin (By similarity). Binds to, but does not hydrolyze mono- and di-adenosine nucleotides . . |
Accessions | ENST00000300291.10 O43809 H3BV41 ENST00000566340.5 ENST00000568822.1 H3BND3 |